Petros Pharmaceuticals, Inc. (PTPI) scores 30 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 0.03, representing a 500% margin of safety. Quantitative score: 43/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.